78 related articles for article (PubMed ID: 21723283)
1. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.
Mazar J; DeBlasio D; Govindarajan SS; Zhang S; Perera RJ
FEBS Lett; 2011 Aug; 585(15):2467-76. PubMed ID: 21723283
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation is associated with invasive phenotype of malignant melanoma.
Koroknai V; Szász I; Hernandez-Vargas H; Fernandez-Jimenez N; Cuenin C; Herceg Z; Vízkeleti L; Ádány R; Ecsedi S; Balázs M
Exp Dermatol; 2020 Jan; 29(1):39-50. PubMed ID: 31602702
[TBL] [Abstract][Full Text] [Related]
3. miR-375 inhibits cell growth and correlates with clinical outcomes in tongue squamous cell carcinoma.
Jia L; Huang Y; Zheng Y; Lyu M; Zhang C; Meng Z; Gan Y; Yu G
Oncol Rep; 2015 Apr; 33(4):2061-71. PubMed ID: 25633534
[TBL] [Abstract][Full Text] [Related]
4. Anti-cancer drugs reactivate tumor suppressor miR-375 expression in tongue cancer cells.
Jung HM; Benarroch Y; Chan EK
J Cell Biochem; 2015 May; 116(5):836-43. PubMed ID: 25521291
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.
Seol HS; Akiyama Y; Shimada S; Lee HJ; Kim TI; Chun SM; Singh SR; Jang SJ
Cancer Lett; 2014 Oct; 353(2):232-41. PubMed ID: 25063738
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance.
Li Y; Jiang Q; Xia N; Yang H; Hu C
J Int Med Res; 2012; 40(5):1662-9. PubMed ID: 23206448
[TBL] [Abstract][Full Text] [Related]
7. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.
Giricz O; Reynolds PA; Ramnauth A; Liu C; Wang T; Stead L; Childs G; Rohan T; Shapiro N; Fineberg S; Kenny PA; Loudig O
J Pathol; 2012 Jan; 226(1):108-19. PubMed ID: 21953071
[TBL] [Abstract][Full Text] [Related]
8. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.
Nishikawa E; Osada H; Okazaki Y; Arima C; Tomida S; Tatematsu Y; Taguchi A; Shimada Y; Yanagisawa K; Yatabe Y; Toyokuni S; Sekido Y; Takahashi T
Cancer Res; 2011 Oct; 71(19):6165-73. PubMed ID: 21856745
[TBL] [Abstract][Full Text] [Related]
9. Serum bta-miRNA-375 as a potential biomarker for the early diagnosis of enzootic bovine leukosis.
Murakami K; Matsunaga T; Matsuzaki T; Naruke Y; Miyauchi S; Kobayashi S; Yoneyama S; Sakai Y; Ichijo T; Hirata TI; Kimura A; Chiba Y; Matsuda KI; Yamada S; Hikono H
PLoS One; 2024; 19(5):e0302868. PubMed ID: 38723001
[TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1.
Mao S; Zheng S; Lu Z; Wang X; Wang Y; Zhang G; Xu H; Huang J; Lei Y; Liu C; Sun N; He J
Transl Lung Cancer Res; 2021 Jul; 10(7):3155-3172. PubMed ID: 34430355
[TBL] [Abstract][Full Text] [Related]
11. Epigenetics and microRNAs in UGT1As.
Meng CL; Zhao W; Zhong DN
Hum Genomics; 2021 May; 15(1):30. PubMed ID: 34034810
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.
Ghafouri-Fard S; Gholipour M; Taheri M
Front Oncol; 2021; 11():608987. PubMed ID: 33968718
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8.
Ge X; Niture S; Lin M; Cagle P; Li PA; Kumar D
Sci Rep; 2021 Mar; 11(1):5660. PubMed ID: 33707587
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets.
Arif KMT; Elliott EK; Haupt LM; Griffiths LR
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050637
[TBL] [Abstract][Full Text] [Related]
15. miR-375 is downregulated by promoter hypermethylation in MIN6 insulinoma cells.
Wei Y; Cai WJ; Kuang XM; Yin L
Int J Clin Exp Pathol; 2018; 11(11):5335-5342. PubMed ID: 31949614
[TBL] [Abstract][Full Text] [Related]
16. Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients.
Bhalla S; Kaur H; Dhall A; Raghava GPS
Sci Rep; 2019 Oct; 9(1):15790. PubMed ID: 31673075
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic Drugs for Cancer and microRNAs: A Focus on Histone Deacetylase Inhibitors.
Autin P; Blanquart C; Fradin D
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658720
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
Jayamohan S; Kannan M; Moorthy RK; Rajasekaran N; Jung HS; Shin YK; Arockiam AJV
Front Oncol; 2019; 9():847. PubMed ID: 31552174
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit.
Provvisiero DP; Negri M; de Angelis C; Di Gennaro G; Patalano R; Simeoli C; Papa F; Ferrigno R; Auriemma RS; De Martino MC; Colao A; Pivonello R; Pivonello C
Sci Rep; 2019 Aug; 9(1):11695. PubMed ID: 31406139
[TBL] [Abstract][Full Text] [Related]
20. Role of miRNAs in Melanoma Metastasis.
Gajos-Michniewicz A; Czyz M
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30866509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
